The Car-T cell therapy was tested on patients with B-cell leukaemia and lymphoma - rare types of blood cancers - that affect the bone marrow and the lymphatic system.

The study, published in The Lancet Haematology, has revealed that the injection had a 73% response rate among Indian patients ...

Bexobrutideg, a first-in-class Bruton’s tyrosine kinase degrader, has been granted orphan drug designation from the FDA in ...

Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for cutting-edge treatment. The CAR T-cell therapy involves the col ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.

BioVaxys common shares are listed on the Canadian Securities Exchange under the stock symbol "BIOV" and trade on the Frankfurt Bourse (FRA: 5LB) and in the U.S. on the OTC Markets (OTCQB marketplace).

Apart from breathing issues like breathlessness and pain in the chest, signs and symptoms of lung cancer extend way beyond, ...

This therapy targets multiple tumor-specific antigens, offering improved treatment precision for blood cancer patients, and significantly reducing costs, thus enhancing accessibility in India and ...

The Work and Pensions Secretary has announced plans to tighten the eligibility criteria for Personal Independence Payment ...

Equities research analysts at Roth Capital issued their FY2029 earnings per share estimates for Cellectar Biosciences in a ...

Canopy, the first Continuous Care Platform for oncology, today announced a multi-year partnership with Texas Oncology, one of the nation's largest community-based oncology practices, encompassing ...